Long Noncoding RNA UPK1A-AS1 Indicates Poor Prognosis of Hepatocellular Carcinoma and Promotes Cell Proliferation Through Interaction with EZH2

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2020 Oct 30

PMID 33121524

Citations 23

Authors

Dong-Yan Zhang

Qing-Can Sun

Xue-Jing Zou

Yang Song

Wen-Wen Li

Ze-Qin Guo

Shan-shan Liu

Li Liu

De-Hua Wu

Affiliations

Soon will be listed here.

Abstract

Background: Dysregulation of long non-coding RNAs (lncRNAs) is responsible for cancer initiation and development, positioning lncRNAs as not only biomarkers but also promising therapeutic targets for cancer treatment. A growing number of lncRNAs have been reported in hepatocellular carcinoma (HCC), but their functional and mechanistic roles remain unclear.

Methods: Gene Set Enrichment Analysis was used to investigate the molecular mechanism of UPK1A antisense RNA 1 (UPK1A-AS1). Cell Counting Kit-8 assays, EdU assays, flow cytometry, western blotting, and xenograft assays were used to confirm the role of UPK1A-AS1 in the proliferation of HCC cells in vitro and in vivo. Bioinformatics analyses and quantitative polymerase chain reaction (qRT-PCR) were performed to explore the interplay between UPK1A-AS1 and enhancer of zeste homologue 2 (EZH2). RNA immunoprecipitation (RIP), RNA pull-down assays, western blotting, and qRT-PCR were conducted to confirm the interaction between UPK1A-AS1 and EZH2. The interaction between UPK1A-AS1 and miR-138-5p was examined by luciferase reporter and RIP assays. Finally, the expression level and prognosis value of UPK1A-AS1 in HCC were analyzed using RNA sequencing data from The Cancer Genome Atlas datasets.

Results: We showed that UPK1A-AS1, a newly identified lncRNA, promoted cellular proliferation and tumor growth by accelerating cell cycle progression. Cell cycle-related genes, including CCND1, CDK2, CDK4, CCNB1, and CCNB2, were significantly upregulated in HCC cells overexpressing UPK1A-AS1. Furthermore, overexpression of UPK1A-AS1 could protect HCC cells from cis-platinum toxicity. Mechanistically, UPK1A-AS1 interacted with EZH2 to mediate its nuclear translocation and reinforce its binding to SUZ12, leading to increased H27K3 trimethylation. Targeting EZH2 with specific small interfering RNA impaired the UPK1A-AS1-mediated upregulation of proliferation and cell cycle progression-related genes. Moreover, miR-138-5p was identified as a direct target of UPK1A-AS1. Additionally, UPK1A-AS1 was significantly upregulated in HCC, and the upregulation of UPK1A-AS1 predicted poor prognosis for patients with HCC.

Conclusions: Our study revealed that UPK1A-AS1 promotes HCC development by accelerating cell cycle progression through interaction with EZH2 and sponging of miR-138-5p, suggesting that UPK1A-AS1 possesses substantial potential as a novel biomarker for HCC prognosis and therapy.

Citing Articles

as a prognostic biomarker and potential therapeutic target in kidney renal clear cell carcinoma.

Zou T, Jia Z, Wu J, Liu X, Deng M, Zhang X Front Immunol. 2025; 15:1521629.

PMID: 39742277 PMC: 11685228. DOI: 10.3389/fimmu.2024.1521629.

Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons.

Goyal H, Parwani S, Kaur J Cell Death Discov. 2024; 10(1):451.

PMID: 39448589 PMC: 11502918. DOI: 10.1038/s41420-024-02200-2.

Implications in Cancer of Nuclear Micro RNAs, Long Non-Coding RNAs, and Circular RNAs Bound by PRC2 and FUS.

Swaminathan G, Rogel-Ayala D, Armich A, Barreto G Cancers (Basel). 2024; 16(5).

PMID: 38473229 PMC: 10930775. DOI: 10.3390/cancers16050868.

The VAX2-LINC01189-hnRNPF signaling axis regulates cell invasion and migration in gastric cancer.

Hong L, Yang P, Zhang L, Liu X, Wei X, Xiao W Cell Death Discov. 2023; 9(1):387.

PMID: 37865686 PMC: 10590441. DOI: 10.1038/s41420-023-01688-4.

KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer.

Yao L, Hao Q, Wang M, Chen Y, Cao H, Zhang Q Oncogene. 2023; 42(47):3514-3528.

PMID: 37845393 PMC: 10656286. DOI: 10.1038/s41388-023-02858-5.

References

Yin Y, Qiu S, Peng Y . Functional roles of enhancer of zeste homolog 2 in gliomas. Gene. 2015; 576(1 Pt 2):189-94. DOI: 10.1016/j.gene.2015.09.080. View

Shi B, Liang J, Yang X, Wang Y, Zhao Y, Wu H . Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol. 2007; 27(14):5105-19. PMC: 1951944. DOI: 10.1128/MCB.00162-07. View

Pan Y, Wang C, Zhu M, Xing R, Cui J, Li W . STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer. Mol Cancer. 2016; 15(1):79. PMC: 5148878. DOI: 10.1186/s12943-016-0561-z. View

Couri T, Pillai A . Goals and targets for personalized therapy for HCC. Hepatol Int. 2019; 13(2):125-137. DOI: 10.1007/s12072-018-9919-1. View

Laugesen A, Hojfeldt J, Helin K . Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation. Mol Cell. 2019; 74(1):8-18. PMC: 6452890. DOI: 10.1016/j.molcel.2019.03.011. View

Abdollahzadeh R, Daraei A, Mansoori Y, Sepahvand M, Amoli M, Tavakkoly-Bazzaz J . Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer. J Cell Physiol. 2018; 234(7):10080-10100. DOI: 10.1002/jcp.27941. View

Du F, Guo T, Cao C . Restoration of UPK1A-AS1 Expression Suppresses Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Cells Partially by Sponging microRNA-1248. Cancer Manag Res. 2020; 12:2653-2662. PMC: 7186006. DOI: 10.2147/CMAR.S239418. View

Khorkova O, Hsiao J, Wahlestedt C . Basic biology and therapeutic implications of lncRNA. Adv Drug Deliv Rev. 2015; 87:15-24. PMC: 4544752. DOI: 10.1016/j.addr.2015.05.012. View

Liu Y, Zhang W, Liu K, Liu S, Ji B, Wang Y . miR-138 suppresses cell proliferation and invasion by inhibiting SOX9 in hepatocellular carcinoma. Am J Transl Res. 2016; 8(5):2159-68. PMC: 4891428. View

10.

Cheng A, Lau S, Chen Y, Kondo Y, Li M, Feng H . EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cancer Res. 2011; 71(11):4028-39. DOI: 10.1158/0008-5472.CAN-10-3342. View

11.

Rimassa L, Pressiani T, Merle P . Systemic Treatment Options in Hepatocellular Carcinoma. Liver Cancer. 2019; 8(6):427-446. PMC: 6883446. DOI: 10.1159/000499765. View

12.

Yan K, Lin C, Liao T, Peng C, Lee S, Liu Y . EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?. Int J Mol Sci. 2017; 18(6). PMC: 5485996. DOI: 10.3390/ijms18061172. View

13.

Erdmann K, Kaulke K, Rieger C, Salomo K, Wirth M, Fuessel S . MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells. J Cancer Res Clin Oncol. 2016; 142(11):2249-61. DOI: 10.1007/s00432-016-2222-4. View

14.

Lin S, Lin Y, Chi H, Lin T, Chen W, Yeh C . A Novel Long Non-Coding RNA-01488 Suppressed Metastasis and Tumorigenesis by Inducing miRNAs That Reduce Vimentin Expression and Ubiquitination of Cyclin E. Cells. 2020; 9(6). PMC: 7348830. DOI: 10.3390/cells9061504. View

15.

Sauvageau M . Diverging RNPs: Toward Understanding lncRNA-Protein Interactions and Functions. Adv Exp Med Biol. 2019; 1203:285-312. DOI: 10.1007/978-3-030-31434-7_10. View

16.

Gan L, Yang Y, Li Q, Feng Y, Liu T, Guo W . Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. Biomark Res. 2018; 6:10. PMC: 5845366. DOI: 10.1186/s40364-018-0122-2. View

17.

Chan J, Tay Y . Noncoding RNA:RNA Regulatory Networks in Cancer. Int J Mol Sci. 2018; 19(5). PMC: 5983611. DOI: 10.3390/ijms19051310. View

18.

Suva M, Riggi N, Janiszewska M, Radovanovic I, Provero P, Stehle J . EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 2009; 69(24):9211-8. DOI: 10.1158/0008-5472.CAN-09-1622. View

19.

Comet I, Riising E, LeBlanc B, Helin K . Maintaining cell identity: PRC2-mediated regulation of transcription and cancer. Nat Rev Cancer. 2016; 16(12):803-810. DOI: 10.1038/nrc.2016.83. View

20.

Xu M, Chen X, Lin K, Zeng K, Liu X, Pan B . The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p. Mol Cancer. 2018; 17(1):141. PMC: 6162892. DOI: 10.1186/s12943-018-0894-x. View